Today's Daily Dose brings you news about approval of the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness; approval of MRK/PFE's Type 2 diabetes drugs and delay in FDA's action on Portola's Biologics License Application for AndexXa.
from RTT - Biotech http://ift.tt/2C2rdx1
via IFTTT
No comments:
Post a Comment